Current challenges in clinical target volume definition: Tumour margins and microscopic extensions

Acta Oncologica

Volumn 51, Issue 8, 2012, Pages 984-995

  Moghaddasi, Leyla ^a,b   Bezak, Eva ^a,b   Marcu, Loredana G ^a,b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ORADEA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; METHIONINE C 11; PROSTATE SPECIFIC ANTIGEN;

BLADDER CANCER; BRACHYTHERAPY; BRAIN METASTASIS; BRAIN RADIATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARCINOMA CELL; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; IRRADIATION; LIVER CANCER; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH VESSEL METASTASIS; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIOSENSITIVITY; RECURRENT CANCER; REVIEW; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; URINARY BLADDER NEOPLASMS;

EID: 84867503985     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.720381     Document Type: Review

References (76)

1. International commission of radiation units and measurements. Prescribing, Recording, and Reporting Photon Beam Therapy, Report no. 50, ICRU: Bethesda; 1993 .
2. Siegel R, N aishadham D, J emal A. C ancer statistics, 2012. CA Cancer J Clin 2012; 62 : 10 - 29 .
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin 2009; 59 : 225 - 49 .
4. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000; 48 : 1015 - 24 .
5. Graham MV, Matthews JW, Harms Sr WB, Emami B, Glazer HS, Purdy JA. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 1994; 29 : 1105 - 17 .
6. Graham M V, Purdy JA, Emami B, Matthews JW, Harms WB. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995; 33 : 993 - 1000 .
7. Ekberg L, Holmberg O, Wittgren L, Bjelkengren G, Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol 1998; 48 : 71 - 7 .
8. Li WL, Yu JM, Liu GH, Zhong WX, Li WW, Zhang BJ. [A comparative study on radiology and pathology target volume in non-small-cell lung cancer]. Zhonghua Zhong Liu Za Zhi 2003; 25 : 566 - 8 .
9. Grills I S, Fitch DL, Goldstein NS, Yan D, Chmielewski GW, Welsh RJ, et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defi ning clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69 : 334 - 41 .
10. T ravis W D, B rambilla E, M uller-Hermelink H K, H arris C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon, France: IARC Press; 2004 .
11. Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 67 : 727 - 34 .
12. Dong M J, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis. Nucl Med Commun 2009; 30 : 639 - 50 .
13. Cotton R E. T he bronchial spread of lung cancer. B r J Disease Chest 1959; 53 : 142 - 50 .
14. K ara M, Sak SD, Orhan D, Yavuzer S. C hanging patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin? Lung Cancer 2000; 30 : 161 - 8 .
15. Partin A W, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specifi c antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277 : 1445 - 51 .
16. Pisansky TM, D avis B J. P redictive factors in localized prostate cancer: Implications for radiotherapy and clinical trial design. Semin Urol Oncol 2000; 18 : 93 - 107 .
17. Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys 2006; 65 : 999 - 1007 .
18. Stamey T A, McNeal JE, Freiha FS, Redwine E. M orphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139 : 1235 - 41 .
19. Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Infl uence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup. J Urol 1993; 150 : 135 - 41 .
20. Davis B J, Pisansky TM, Wilson TM, Rothenberg HJ, Pacelli A, Hillman DW, et al. The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy. Cancer 1999; 85 : 2630 - 7 .
21. Sohayda C, Kupelian PA, Levin HS, Klein EA. E xtent of extracapsular extension in localized prostate cancer. Urology 2000; 55 : 382 - 6 .
22. Teh B S, Bastasch MD, Mai WY, Butler EB, Wheeler TM. Predictors of extracapsular extension and its radial distance in prostate cancer: Implications for prostate IMRT, brachytherapy, and surgery. Cancer J 2003; 9 : 454 - 60 .
23. Teh BS, Bastasch MD, Wheeler TM, Mai WY, Frolov A, Uhl BM, et al. IMRT for prostate cancer: Defi ning target volume based on correlated pathologic volume of disease. Int J Radiat Oncol Biol Phys 2003; 56 : 184 - 91 .
24. Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, et al. Prediction of radial distance of extraprostatic extension from pretherapy factors. Int J Radiat Oncol Biol Phys 2007; 69 : 411 - 8 .
25. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10 : 459 - 66 .
26. Jansen E P, Dewit LG, van Herk M, Bartelink H. T arget volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 2000; 56 : 151 - 6 .
27. Seither R B, Jose B, Paris KJ, Lindberg RD, Spanos WJ. Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995; 18 : 297 - 9 .
28. Nelson DF, Curran Jr WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, et al. Hyperfractionated radiation therapy and bischlorethyl nitrosourea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302. Int J Radiat Oncol Biol Phys 1993; 25 : 193-207
29. Urtasun RC, Kinsella TJ, Farnan N, DelRowe JD, Lester SG, Fulton DS. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: Final report of RTOG 86-12, phase I - II study. Int J Radiat Oncol Biol Phys 1996; 36 : 1163 - 7 .
30. Chang E L, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 2007; 68 : 144 - 50 .
31. Matsuo M, Miwa K, Tanaka O, Shinoda J, Nishibori H, Tsuge Y, et al. Impact of [(11)C]methionine positron emission tomography for target defi nition of glioblastoma multiforme in radiation therapy planning. Int J Radiat Oncol Biol Phys 2012; 82 : 83 - 90 .
32. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral glioma: Evaluation with methionine PET. Radiology 1993; 186 : 45 - 53 .
33. M inniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010 ; 97 : 377 - 81 .
34. Engenhart R, Kimmig BN, Hover KH, Wowra B, Romahn J, Lorenz WJ, et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 1993; 71 : 1353 - 61 .
35. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998; 16 : 3563 - 9 .
36. Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, et al. Stereotactic radiosurgery for the treatment of brain metastases. Cancer 1997; 79 : 551 - 7 .
37. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006; 295 : 2483 - 91 .
38. Noel G, Simon JM, Valery CA, Cornu P, Boisserie G, Hasboun D, et al. Radiosurgery for brain metastasis: Impact of CTV on local control. Radiother Oncol 2003; 68 : 15 - 21 .
39. Nataf F, Schlienger M, Liu Z, Foulquier JN, Gres B, Orthuon A, et al. Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 2008; 70 : 766 - 72 .
40. Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008; 70 : 187 - 93 .
41. Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GRt, Lieberson RE, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: Prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys Epub 2012 May 30 .
42. Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, et al. A pathology-based substrate for target defi nition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006; 66 : 187 - 94 .
43. Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, et al. Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 2009; 110 : 730 - 6 .
44. Raore B, Schniederjan M, Prabhu R, Brat DJ, Shu HK, Olson JJ. Metastasis infi ltration: An investigation of the postoperative brain-tumor interface. Int J Radiat Oncol Biol Phys 2010;81: 1075 - 80 .
45. Holland R, Veling SHJ, Mravunac M, H endriks JHCL. Histologic multifocality of tis, T1 - 2 breast carcinomas implications for clinical trials of breast-conserving surgery. Cancer 1985; 56 : 979 - 90 .
46. Kirby AM, C oles C E, Y arnold J R. T arget volume defi nition for external beam partial breast radiotherapy: Clinical, pathological and technical studies informing current approaches. Radiother Oncol 2010; 94 : 255 - 63 .
47. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1988; 14 : 3 - 10 .
48. Healey EA, Osteen RT, Schnitt SJ, Gelman R, Stomper PC, Connolly JL, et al. Can the clinical and mammographic fi ndings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys 1989; 17 : 1217 - 21 .
49. Eberlein T J, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris Jr. Predictors of local recurrence following conservative breast surgery and radiation therapy. The infl uence of tumor size. Arch Surg 1990; 125 : 771 - 5; discussion 775 - 7.
50. Vicini F A, Eberlein TJ, Connolly JL, Recht A, Abner A, Schnitt SJ, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991; 214 : 200 - 4; discussion 204 - 5.
51. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8 : 113 - 8 .
52. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335 : 519 - 22 .
53. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995; 76 : 32 - 45 .
54. Imamura H, Haga S, Shimizu T, Watanabe O, Kinoshita J, Nagumo H, et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 2000; 62 : 177 - 84 .
55. Swanson T A, V icini FA. O verview of accelerated partial breast irradiation. Curr Oncol Rep 2008; 10 : 54 - 60 .
56. Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, et al. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990; 19 : 29 - 41 .
57. V icini F A, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol 2001 ; 19 : 1993 - 2001 .
58. Vicini F A, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-fi eld radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95 : 1205 - 10 .
59. Vicini FA, K estin LL, G oldstein NS. D efi ning the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004; 60 : 722 - 30 .
60. Kirby AM, Evans PM, Nerurkar AY, Desai SS, Krupa J, Devalia H, et al. How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume defi nition for partialbreast radiotherapy? Radiother Oncol 2010; 94 : 292 - 9 .
61. Hanbeukers B, Borger J, van den Ende P, van der Ent F, Houben R, Jager J, et al. Customized computed tomographybased boost volumes in breast-conserving therapy: Use of three-dimensional histologic information for clinical target volume margins. Int J Radiat Oncol Biol Phys 2009;75 : 757 - 63 .
62. Stroom J, Schlief A, Alderliesten T, Peterse H, Bartelink H, Gilhuijs K. Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy. Int J Radiat Oncol Biol Phys 2009; 74 : 898 - 905 .
63. Ho C M, Ng WF, Lam KH, Wei WJ, Yuen AP. S ubmucosal tumor extension in hypopha ryngeal cancer. Arch Otolaryngol Head Neck Surg 1997; 123 : 959 - 65 .
64. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving defi nitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002; 53 : 1174 - 84 .
65. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003; 69 : 227 - 36 .
66. Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 2006; 64 : 678 - 83 .
67. Johnson JT, Barnes EL, Myers EN, Schramm VL, Jr., Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981; 107 : 725 - 9 .
68. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL, Jr., Thearle PB. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985; 111 : 534 - 7 .
69. Snyderman NL, Johnson JT, Schramm VL, Jr., Myers EN, Bedetti CD, Thearle P. Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer 1985; 56 : 1597 - 9 .
70. Jenkins P, Anjarwalla S, Gilbert H, Kinder R. Defi ning the clinical target volume for bladder cancer radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 2009; 75 : 1379 - 84 .
71. Wang W, Feng X, Zhang T, Jin J, Wang S, Liu Y, et a l. Prospective evaluation of microscopic extension using wholemount preparation in patients with hepatocellular carcinoma: Defi nition of clinical target volume for radiotherapy. Radiat Oncol 2010; 5 : 73 .
72. Wang M H, Ji Y, Zeng ZC, Tang ZY, Fan J, Zhou J, et a l. I mpact factors for microinvasion in patients with hepatocellular carcinoma: Possible application to the defi nition of clinical tumor volume. Int J Radiat Oncol Biol Phys 2010; 76 : 467 - 76 .
73. H offman MS, Gunesakaran S, Arango H, DeCesare S, Fiorica JV, Parsons M, et al. Lateral microscopic extension of squamous cell carcinoma of the vulva. Gynecol Oncol 1999 ; 73 : 72 - 5 .
74. Choo R, Woo T, Assaad D, Antonyshyn O, Barnes EA, McKenzie D, et al What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers? Int J Radiat Oncol Biol Phys 2005; 62 : 1096 - 9 .
75. Fennimore IA, Simon NL, Bills G, Dryfhout VL, Schniederjan AM. Extension of ovarian tissue into the infundibulopelvic ligament beyond visual margins. Gynecol Oncol 2009; 114 : 61 - 3 .
76. Hong TS, W A. Tome, Harari P M. H eterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol 2012; 103 : 92 - 8.